JORDAN TILLER: Open Payments
NPI 1629746177 · ROYSTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 23 payments from 9 companies in 2025. Trend: 2023 $246 · 2024 $380 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $215 |
| Boston Scientific Corporation | 2 | $149 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $127 |
| Amgen Inc. | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| CVRx, Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: WAINUA, LifeVest, Rhythmia Mapping System, REPATHA, LEQVIO, BodyGuardian, Barostim Neo System, VERQUVO.
Industry payments across GA — which companies pay providers there.
